Premium
PMCA 4b as tumor suppressor: The C a 2+ line as therapeutic avenue in cancer
Author(s) -
Parys Jan B.
Publication year - 2016
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.30495
Subject(s) - vemurafenib , cancer research , carcinogenesis , mapk/erk pathway , selumetinib , cell growth , melanoma , cancer , biology , neuroblastoma ras viral oncogene homolog , microbiology and biotechnology , signal transduction , chemistry , medicine , mek inhibitor , biochemistry , kras , colorectal cancer , metastatic melanoma